ZKB CALLABLE BARRIER REVERSE CONVERTIBLE ON WORST OF - NOVARTIS N/SANOFI/ROCHE GS/BAYER Share Price

Certificat

Z0958Z

CH1329104249

Market Closed - Swiss Exchange 16:20:00 22/05/2024 BST
102.2 CHF +0.03% Intraday chart for ZKB CALLABLE BARRIER REVERSE CONVERTIBLE ON WORST OF - NOVARTIS N/SANOFI/ROCHE GS/BAYER
Current month+2.39%
1 month+4.14%
Date Price Change

Delayed Quote Swiss Exchange

Last update May 22, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer ZKB
Z0958Z
ISINCH1329104249
Date issued 26/02/2024
Strike 229.2 CHF
Maturity 26/08/2025 (455 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 102.2 CHF
Lowest since issue 97.05 CHF
Spread 7 CHF
Spread %0.68%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
228.8 CHF
Average target price
279.8 CHF
Spread / Average Target
+22.30%
Consensus
  1. Stock Market
  2. Certificates
  3. Z0958Z Certificat